ZFP36 and rheumatoid arthritis: have reported that compared with AA/AG genotypes, GG genotype in ZFP36 promoter region SNP, in which promoter activity is lower than that with AA/AG genotypes, is associated with age at onset, duration, disease progression, and infliximab usage in Japanese RA patients (43).